PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 40 filers reported holding PROTAGONIST THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,277,087 | -34.9% | 76,564 | +7.8% | 0.00% | -100.0% |
| Q2 2023 | $1,962,429 | +151.2% | 71,051 | +109.2% | 0.00% | – |
| Q1 2023 | $781,172 | +193259.4% | 33,964 | +91694.6% | 0.00% | – |
| Q4 2022 | $404 | -97.9% | 37 | -98.4% | 0.00% | – |
| Q3 2022 | $19,000 | -56.8% | 2,344 | -58.3% | 0.00% | – |
| Q2 2022 | $44,000 | -92.9% | 5,625 | -78.4% | 0.00% | – |
| Q1 2022 | $616,000 | -55.4% | 26,019 | -35.5% | 0.00% | – |
| Q4 2021 | $1,380,000 | +32.4% | 40,358 | -31.3% | 0.00% | – |
| Q3 2021 | $1,042,000 | -22.6% | 58,729 | +95.6% | 0.00% | – |
| Q2 2021 | $1,346,000 | +35.3% | 30,018 | -21.9% | 0.00% | – |
| Q1 2021 | $995,000 | -32.9% | 38,435 | -47.7% | 0.00% | – |
| Q4 2020 | $1,483,000 | +188.5% | 73,531 | +180.2% | 0.00% | – |
| Q3 2020 | $514,000 | +94.0% | 26,244 | +75.3% | 0.00% | – |
| Q2 2020 | $265,000 | -22.7% | 14,969 | -69.2% | 0.00% | – |
| Q1 2020 | $343,000 | +44.7% | 48,545 | +45.0% | 0.00% | – |
| Q4 2019 | $237,000 | -24.0% | 33,478 | +28.9% | 0.00% | – |
| Q3 2019 | $312,000 | +25.8% | 25,974 | +26.4% | 0.00% | – |
| Q2 2019 | $248,000 | +21.0% | 20,553 | +25.9% | 0.00% | – |
| Q1 2019 | $205,000 | +66.7% | 16,329 | -11.0% | 0.00% | – |
| Q4 2018 | $123,000 | -5.4% | 18,345 | +45.6% | 0.00% | – |
| Q3 2018 | $130,000 | +46.1% | 12,601 | -4.6% | 0.00% | – |
| Q2 2018 | $89,000 | +21.9% | 13,205 | +54.5% | 0.00% | – |
| Q1 2018 | $73,000 | -36.5% | 8,545 | +55.4% | 0.00% | – |
| Q4 2017 | $115,000 | -32.0% | 5,500 | -42.5% | 0.00% | – |
| Q3 2017 | $169,000 | +152.2% | 9,565 | +60.8% | 0.00% | – |
| Q2 2017 | $67,000 | 0.0% | 5,948 | +14.0% | 0.00% | – |
| Q1 2017 | $67,000 | -41.7% | 5,219 | 0.0% | 0.00% | – |
| Q4 2016 | $115,000 | – | 5,219 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $19,373,000 | 4.95% |
| Bain Capital Life Sciences Investors, LLC | 2,260,572 | $17,881,000 | 2.10% |
| Finepoint Capital LP | 735,126 | $5,815,000 | 2.01% |
| Altium Capital Management LP | 365,100 | $2,888,000 | 1.16% |
| RTW INVESTMENTS, LP | 4,794,499 | $37,924,000 | 0.98% |
| Amitell Capital Pte Ltd | 50,129 | $397,000 | 0.90% |
| COWEN AND COMPANY, LLC | 1,065,724 | $8,430,000 | 0.81% |
| Tri Locum Partners LP | 155,000 | $1,226,000 | 0.50% |
| BVF INC/IL | 1,106,838 | $8,755,000 | 0.42% |
| HighVista Strategies LLC | 46,459 | $367,000 | 0.22% |